As of 2025-07-11, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 23.77 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.14 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 1010.6%.
The range of the Relative Valuation is 13.34 - 37.94 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 26.3x | 24.9x |
| Forward P/E multiples | 16.7x - 24.9x | 19.1x |
| Fair Price | 13.34 - 37.94 | 23.77 |
| Upside | 523.2% - 1672.7% | 1010.6% |
| Date | P/E |
| 2025-07-10 | 4.81 |
| 2025-07-09 | 4.94 |
| 2025-07-08 | 4.40 |
| 2025-07-03 | 4.06 |
| 2025-07-02 | 3.92 |
| 2025-07-01 | 3.20 |
| 2025-06-27 | 3.93 |
| 2025-06-25 | 3.66 |
| 2025-06-24 | 3.72 |
| 2025-06-23 | 3.78 |
| 2025-06-20 | 3.89 |
| 2025-06-16 | 3.18 |
| 2025-06-13 | 3.25 |
| 2025-06-12 | 3.18 |
| 2025-06-11 | 3.11 |
| 2025-06-10 | 2.84 |
| 2025-06-06 | 3.05 |
| 2025-06-05 | 2.98 |
| 2025-06-04 | 2.84 |
| 2025-06-03 | 2.67 |
| 2025-06-02 | 2.71 |
| 2025-05-29 | 2.57 |
| 2025-05-28 | 2.57 |
| 2025-05-27 | 2.64 |
| 2025-05-23 | 2.71 |
| 2025-05-22 | 2.44 |
| 2025-05-21 | 2.23 |
| 2025-05-19 | 2.63 |
| 2025-05-15 | 2.63 |
| 2025-05-14 | 2.63 |
| 2025-05-13 | 2.67 |
| 2025-05-12 | 2.69 |
| 2025-05-09 | 2.69 |
| 2025-05-08 | 2.57 |
| 2025-05-07 | 2.57 |
| 2025-05-06 | 2.57 |
| 2025-05-05 | 2.67 |
| 2025-05-02 | 2.67 |
| 2025-04-30 | 2.65 |
| 2025-04-29 | 2.65 |
| 2025-04-28 | 2.60 |
| 2025-04-25 | 2.30 |
| 2025-04-24 | 2.03 |
| 2025-04-23 | 2.67 |
| 2025-04-22 | 2.23 |
| 2025-04-17 | 2.44 |
| 2025-04-16 | 2.19 |
| 2025-04-15 | 2.44 |
| 2025-04-14 | 1.69 |